ESC 365 - Noradrenaline combined with either dobutamine or levosimendan - similar outcome and cardiac biomarker evolution in cardiogenic shock

Back

HFA Premium Access

Noradrenaline combined with either dobutamine or levosimendan - similar outcome and cardiac biomarker evolution in cardiogenic shock

Session: Rapid Fire 1 - Acute heart failure

Topic: Acute heart failure (other)

Speaker: Doctor T. Tarvasmaki (Helsinki, FI)

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Doctor Tuukka Tarvasmaki

Helsinki University Hospital, Helsinki (Finland)

0 follower

14 more presentations in this session

Twenty five years of acute heart failure in 1800 consecutive patients: no short- and long-term survival improvement.

Speaker: Mr J. van den Berge (Rotterdam, NL)

Prognostic significance of multi-organ dysfunction/damage in acute heart failure

Speaker: Doctor R. Zymlinski (Wroclaw, PL)

Clinical characteristics and prognosis of patients hospitalized for heart failure depending on ejection fraction: analysis of administrative data of a nationwide population

Speaker: Doctor R. Bover Freire (Madrid, ES)

Combined measurement of sST2 and NT-proBNP is a very early marker of severity in cardiogenic shock complicating acute coronary syndromes

Speaker: Doctor H. Tolppanen (Helsinki, FI)

Access

Abstract

Short and long-term prognostic value of hyponatremia in heart failure with preserved ejection fraction versus reduced ejection fraction: An analysis of the Korean Acute Heart Failure (KorAHF) Registry

Speaker: Assistant Professor J. Park (Seongnam, KR)

Access the full session

Rapid Fire 1 - Acute heart failure

Speakers: Doctor T. Tarvasmaki, Mr J. van den Berge, Doctor R. Zymlinski, Doctor R. Bover Freire, Doctor H. Tolppanen...

Access

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources